Anita Gupta

From Wikitia
Jump to navigation Jump to search
Anita Gupta
Anita Gupta.jpg
Dr. Anita Gupta, 2019, Milken Institute, Global Forum, Los Angeles, USA.
EducationHarvard Business School (GMP)
Princeton University (MPP and HHP)
University of Medicine and Dentistry of New Jersey / Rowan University (DO)
Ernest Mario School of Pharmacy
Scientific career
FieldsChief Executive, Medicine, Health Policy
InstitutionsJohns Hopkins School of Medicine
Food and Drug Administration
Organon & Co.
Websitewww.anitagupta.com

Anita Gupta is a chief executive, medical doctor-pharmacist.[1][2][3][4]

Early life and education

Gupta was born and raised in Philadelphia. Her mother was a teacher, and her father was a veterinarian. After graduation from high school, she attended The College of New Jersey for two years later transferring to the Ernest Mario School of Pharmacy completing dual-degrees in pharmacy (B.S) and a doctorate in pharmacy (Pharm.D.). She then worked at Organon & Co. now Merck & Co., Inc. when she was then later attended medical school at Rowan University School of Osteopathic Medicine where she pursued her doctorate of osteopathic medical degree (D.O.). She then completed her anesthesiology residency at Georgetown University School of Medicine and interventional pain fellowship at Johns Hopkins School of Medicine.[5] In 2018, Gupta graduated from Princeton University[6] with a master's in public policy (MPP, HHP) and in 2020 from Harvard Business School from the General Management Program. She was named an ambassador[7] to the Harvard Business School General Management Program and was the speaker of the graduating business school class. In 2022, she was named regional co-president of the Harvard-I Alumnae Network of Women and regional director of the Harvard Business School Healthcare Alumni Association. She is the first physician graduate of both Princeton University and Harvard Business School.

Career

Gupta was appointed at University of Pennsylvania as faculty after completing her medical residency and later she spent 10 years at Tenet Healthcare, Hahnemann University Hospital working on the opioid crisis[8] and intractable pain. During her work in Philadelphia she was appointed as an advisor to the U.S. Food and Drug Administration and became an public health advocate for the expansion of the opioid antidote naloxone[9] in coordination with the American Society of Anesthesiologists and the FDA in 2015. In 2016, she noted that a case of naloxone resistance[10] in Philadelphia due to increasing synthetic opioids in illicit substance use. She worked with Heron Therapeutics[11] to address breakthrough development of a non-opioid alternative to address the unmet needs of patients. In 2019, she was appointed to the Global Forum of the National Academies of Sciences, Engineering, and Medicine. In 2021, Gupta became the chief executive of the Strata Group, Inc, where she led HealthPivot.org,[12] during the peak emergence COVID-19[13] on vaccines, prevention,[14][15][16][17][18] and treatments.[19][20][21]

Awards

  • In 2020, awarded Global Emerging Leaders by Pharmaceutical Executives award[22]
  • In 2020, awarded Top 100 Inspiring Leaders by PharmaVoice.[23]
  • In 2020, endorsed as a candidate to lead the Food and Drug Administration by Healthy Women[24]
  • named 2021 Fierce Healthcare's Top 10 Women of Influence.[25]
  • In 2022, she was awarded the Patient Advocacy Award by the National Academies of Practices.

Books

  • Interventional Pain Medicine
  • Pharmacology in Anesthesia Practice
  • 50 Studies Every Anesthesiologist Should Know (Fifty Studies Every Doctor Should Know)

Fellowships

  • Johns Hopkins School of Medicine[26][27]

References

  1. ↑ Blum, Dani (2022-01-19). "I Had Breakthrough Covid. Can I Start Living Like It's 2019?". The New York Times. ISSN 0362-4331. Retrieved 2022-02-23.
  2. ↑ "Anita Gupta". Forbes Business Council. Forbes. Retrieved 2022-02-23.
  3. ↑ Gonzalez, Georgina (2021-12-15). "Sustainability, data analytics and more: 3 trends in the future of healthcare". Becker's Hospital Review. Retrieved 2022-02-23.
  4. ↑ Putka, Sophie (2021-11-18). "Are Doctors Comfortable With Holiday Gatherings This Year?". MedPage Today. Retrieved 2022-02-23.
  5. ↑ Ravindranath, Mohana (2020-12-07). "Maintaining telehealth's momentum". Politico. Retrieved 2022-02-26.
  6. ↑ Daugherty, Elisabeth H. (2020-09-02). "Sept. 1: Jeff Bezos '86 breaks $200 billion; Anita Gupta *18 manages COVID pain". Princeton Alumni Weekly. The Trustees of Princeton University. Retrieved 2022-02-23.
  7. ↑ "Transformation in the Classroom and the Frontlines". Executive Education. Harvard Business School. Retrieved 2022-02-23.
  8. ↑ Miller, Janel (2021-08-03). "Opioid tapering significantly increases risk for overdose, mental health crisis". Healio. Retrieved 2022-02-23.
  9. ↑ "ASA Urges Expanded Access to Naloxone at FDA Meeting". American Society of Anesthesiologists. 2015-07-06. Retrieved 2022-02-23.
  10. ↑ "Anesthesiologist Links Antidote Resistance to Killer Synthetic Opioid W-18". Newswise. 2016-05-24. Retrieved 2022-02-23.
  11. ↑ "Heron Therapeutics Granted FDA Fast Track Designation for HTX-011 to Reduce Postoperative Pain and the Need for Opioid Analgesics for 72 Hours" (Press release). San Diego: Business Wire. 2017-10-26. Retrieved 2022-02-23.
  12. ↑ Weaver, Stephanie (2021-01-28). "Taking common pain relievers before COVID-19 vaccination could lessen efficacy, experts say". Fox 32 Chicago. Los Angeles. Retrieved 2022-02-23.
  13. ↑ "Dr. Anita Gupta: 'We need more information on how immunity will be developed with vaccine'". Yahoo! News. Fox News. 2020-10-17. Retrieved 2022-02-23.
  14. ↑ "Avoid Taking Pain Relievers Before COVID-19 Vaccination, Health Expert Says". The Washington Informer. 2021-01-29. Retrieved 2022-02-26.
  15. ↑ Milbrand, Lisa (2021-01-28). "Experts Now Recommend Double Masking to Prevent the Spread of COVID—Here's How to Do It Right". Real Simple. Retrieved 2022-02-23.
  16. ↑ Clopton, Jennifer (2021-02-03). "COVID FAQ: I Got the Vaccine. Is Life Normal Again?". WebMD. Retrieved 2022-02-23.
  17. ↑ Puckett, Jason; Chamberlin, Mauricio; Bawab, Nashwa (2021-01-28). "VERIFY: Ibuprofen/Acetaminophen should be avoided before getting vaccine, but OK afterward". KUSA (TV). Retrieved 2022-02-23.
  18. ↑ Wade, Grace (2022-02-27). "What Is 'Flurona'? COVID-19 and Flu Coinfections, Explained". Health (magazine). ISSN 1059-938X. Retrieved 2022-02-23.
  19. ↑ Butch, Rachel (2020-12-15). "Covid-19 Story Tip: What's an Emergency Use Authorization? Johns Hopkins Medicine Expert Explains in Video". Johns Hopkins Medicine Newsroom. Retrieved 2022-02-23.
  20. ↑ Miller, Ryan W.; Pitofsky, Marina (2022-01-04). "What to do if you test positive for COVID-19 or are exposed: The latest guidance". USA Today. Retrieved 2022-02-23.
  21. ↑ Smith, Jake (2021-12-17). "FDA Approves First Monoclonal Antibody Treatment for Preventing COVID-19, AstraZeneca's Evusheld". Prevention (magazine). Retrieved 2022-02-23.
  22. ↑ "Pharmaceutical Executive® Announces Winners of the 2020 Emerging Pharma Leaders Awards". www.bloomberg.com. 2020-05-13. Retrieved 2022-02-23.
  23. ↑ "PharmaVOICE 100 Who's on the List - By Category". PharmaVoice. Retrieved 2022-02-23.
  24. ↑ "Statement for Dr. Anita Gupta from HealthyWomen". HealthyWomen. 2021-02-28. Retrieved 2022-02-23.
  25. ↑ Landi, Heather (2021-11-08). "Fierce Healthcare's 2021 Women of Influence Awards". Fierce Healthcare. Retrieved 2022-02-23.
  26. ↑ "Anita Gupta, DO, PharmD, MPP – Johns Hopkins Anesthesiology & Critical Care Medicine". anesthesiology.hopkinsmedicine.org. Retrieved 2022-02-23.
  27. ↑ Gupta, Anita. "Council Post: The Future Of Health: Three Healthcare Trends For 2022". Forbes. Retrieved 2022-02-23.

External links

Add External links

This article "Anita Gupta" is from Wikipedia. The list of its authors can be seen in its historical. Articles taken from Draft Namespace on Wikipedia could be accessed on Wikipedia's Draft Namespace.

Retrieved from "https://wikitia.com/index.php?title=Anita_Gupta&oldid=144039"